Figure 5.

Prognostic value of the risk model of the 12 m⁶A-related lncRNAs in the TCGA testing and entire sets

(A) Distribution of m⁶A-related lncRNA model-based risk score for the testing set. (B) Patterns of the survival time and survival status between the high- and low-risk groups for the testing set. (C) Clustering analysis heatmap shows the display levels of the 12 prognostic lncRNAs for each patient in the testing set. (D) Kaplan-Meier survival curves of the OS of patients in the high- and low-risk groups for the testing set. (E) Distribution of the m⁶A-related lncRNA model-based risk score for the entire set. (F) Patterns of the survival time and survival status between the high- and low-risk groups for the entire set. (G) Clustering analysis heatmap shows the expression levels of the 12 prognostic lncRNAs for each patient for the entire set. (H) Kaplan-Meier survival curves of OS of patients in the low- and high-risk groups for the entire set.